Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

ULCA study shows men who married below 25 years of age had lower bone strength

Marriage is good for the health of men's bones - but only if they marry when they're 25 or older, new UCLA researcher suggests.

23 Jan 2014

Nearly half of hospitalized American adults age 65 require decision-making assistance

Nearly half of hospitalized American adults age 65 and older require decision-making assistance from family members or other surrogates because the patient is too impaired to make decisions independently, according to a new study from the Regenstrief Institute and the Indiana University Center for Aging Research.

23 Jan 2014

EnVivo Pharmaceuticals starts encenicline Phase 3 study in patients with Alzheimer's disease

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.

22 Jan 2014

Scientists identify specific enzyme essential for brain development

Scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna have identified a specific enzyme, histone deacetylase 2 (HDAC2), as essential for brain development. The findings published in Development are important to advance the development of new drugs to treat neurological diseases.

22 Jan 2014

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the Italian biochemist Elena Conti, Director of the Department of Structural Cell Biology at the Max-Planck Institute of Biochemistry in Munich (Germany) and to Denis Le Bihan, the French medical doctor, physicist and Director of NeuroSpin, an institute at the French Nuclear and Renewable Energy Commission (CEA) at Saclay near Paris.

22 Jan 2014

Researchers demonstrate existence of an epigenetic lesion in hippocampus of Alzheimer patients

Alzheimer's disease can reach epidemic range in the coming decades, by the increasing average age of society. There are two key issues for Alzheimer's disease: there is currently no effective treatment and it has been described very few associated genetic changes (mutations) which reduces the number of targets for future therapies.

22 Jan 2014

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

21 Jan 2014

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Dakim, Inc., the leader in cognitive therapy in the senior living market, has introduced BrainTrac, a new tool that monitors the cognitive performance of residents in senior living communities who use the Dakim BrainFitness system.

21 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

Research shows how architecture of brain shapes its functioning

The structure of the human brain is complex, reminiscent of a circuit diagram with countless connections. But what role does this architecture play in the functioning of the brain?

20 Jan 2014

Researchers identify protein in brain that plays critical role in memory loss seen in Alzheimer's patients

Cleveland Clinic researchers have identified a protein in the brain that plays a critical role in the memory loss seen in Alzheimer's patients, according to a study to be published in the journal Nature Neuroscience and posted online today.

20 Jan 2014

President Obama signs law to increase funding for Alzheimer's research, education

At the urging of the Alzheimer's Association and its more than 600,000 advocates, the funding bill signed into law today by President Obama contained an unprecedented $122 million increase for Alzheimer's research, education, outreach and caregiver support. The Alzheimer's Association applauds the Obama administration for calling for increased Alzheimer's funding in the President's Fiscal Year 2014 budget and Congress for providing funding to enable the continued, effective implementation of the National Plan to Address Alzheimer's Disease.

18 Jan 2014

Researcher finds possible way to unravel misfolded proteins by reprogramming yeast protein

At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.

17 Jan 2014

Research uncovers new mechanism in brain cells that may help keep deadly neurological diseases in check

New research from David Westaway, PhD, of the University of Alberta and Jiri Safar, MD, Case Western Reserve University School of Medicine has uncovered a quality control mechanism in brain cells that may help keep deadly neurological diseases in check for months or years.

17 Jan 2014

Higher vitamin D levels linked with better cognition and less depression in PD patients

A new study exploring vitamin D levels in patients with Parkinson's disease (PD) opens up the possibility of a new avenue of early intervention that may delay or prevent the onset of cognitive impairment and depression. The findings are published in the Journal of Parkinson's Disease.

16 Jan 2014

Study explores the role of DNA in predisposing individuals to diseases

A group of international researchers, led by a research fellow in the Harvard Medical School-affiliated Institute for Aging Research at Hebrew SeniorLife, published a paper today in Cell describing a study aimed at better understanding how inherited genetic differences, or variants, predispose certain individuals to develop diseases such as type 2 diabetes.

16 Jan 2014

Research findings may offer new way to treat prion diseases

New research from David Westaway, PhD, of the University of Alberta and Jiri Safar, PhD, Case Western Reserve University School of Medicine has uncovered a quality control mechanism in brain cells that may help keep deadly neurological diseases in check for months or years.

16 Jan 2014

Heavy drinking associated with faster decline in cognitive function in middle-aged men

Middle-aged men who drink more than 36 grams of alcohol, or two and a half US drinks per day, may speed their memory loss by up to six years later on, according to a study published in the January 15, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Jan 2014

Cognigram can detect early signs of MCI and Alzheimer’s disease

For patients over the age of 50, a routine physical exam at the doctor’s office typically covers a wide spectrum of medical biomarkers with one glaring exception, cognitive health. Unless there have been unusual mental changes or challenges in their daily life, tests of a patient’s attention, memory or brain processing speed is usually not part of a check-up.

15 Jan 2014

Presence of gene variant in people with MCI associated with accelerated rates of brain atrophy

The presence of a gene variant in people with mild cognitive impairment is associated with accelerated rates of brain atrophy, according to a new study published online in the journal Radiology.

15 Jan 2014

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

ULCA study shows men who married below 25 years of age had lower bone strength

Nearly half of hospitalized American adults age 65 require decision-making assistance

EnVivo Pharmaceuticals starts encenicline Phase 3 study in patients with Alzheimer's disease

Scientists identify specific enzyme essential for brain development

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

Researchers demonstrate existence of an epigenetic lesion in hippocampus of Alzheimer patients

Magnetoencephalography can be used to control and train specific targeted brain regions

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Research shows how architecture of brain shapes its functioning

Researchers identify protein in brain that plays critical role in memory loss seen in Alzheimer's patients

President Obama signs law to increase funding for Alzheimer's research, education

Researcher finds possible way to unravel misfolded proteins by reprogramming yeast protein

Research uncovers new mechanism in brain cells that may help keep deadly neurological diseases in check

Higher vitamin D levels linked with better cognition and less depression in PD patients

Study explores the role of DNA in predisposing individuals to diseases

Research findings may offer new way to treat prion diseases

Heavy drinking associated with faster decline in cognitive function in middle-aged men

Cognigram can detect early signs of MCI and Alzheimer’s disease

Presence of gene variant in people with MCI associated with accelerated rates of brain atrophy

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in